Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

AgeX Therapeutics, Inc. (AGE)

NYSE American - Nasdaq Real Time Price. Currency in USD
0.5500-0.0060 (-1.08%)
At close: 03:58PM EST
0.5679 +0.02 (+3.25%)
After hours: 07:58PM EST
Advertisement
Full screen
Loading interactive chart...
  • Business Wire

    AgeX Therapeutics Receives Extension of Time to Attain Compliance With Stock Exchange Continued Listing Requirements

    ALAMEDA, Calif., November 25, 2022--AgeX Therapeutics, Inc. ("AgeX": NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration, announced today that on November 22, 2022 it received notification from the staff of the NYSE American (the "Exchange") that the Exchange has accepted a revised listing compliance plan from AgeX and has granted AgeX an extension of time to regain compliance with the Exchange’s continued listing standards as set forth in Sectio

  • Business Wire

    AgeX Therapeutics Reports Third Quarter 2022 Financial Results

    ALAMEDA, Calif., November 10, 2022--AgeX Therapeutics, Inc. ("AgeX"; NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration, reported its financial and operating results for the quarter ended September 30, 2022.

  • Business Wire

    AgeX Therapeutics Reports Second Quarter 2022 Financial Results

    ALAMEDA, Calif., August 12, 2022--AgeX Therapeutics, Inc. ("AgeX"; NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration, reported its financial and operating results for the quarter ended June 30, 2022.

Advertisement
Advertisement